XML 262 R205.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial expenses and income (Details) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of detailed information about finance income expense [Line Items]      
Cost of debt [1] € (599) € (552) [2] € (362) [2]
Interest income [3] 413 527 [2] 239 [2]
Cost of net debt (186) (25) [2] (123) [2]
Non-operating foreign exchange gains/(losses) 6 (2) [2] (3) [2]
Unwinding of discounting of provisions [4] (44) (51) [2] (17) [2]
Net interest cost related to employee benefits (64) (70) [2] (46) [2]
Gains/(losses) on disposals of financial assets 0 (1) [2] 1 [2]
Net interest expense on lease liabilities (42) (37) [2] (40) [2]
Other [5] (224) (523) [2] 3 [2]
Net financial income/(expenses) (554) (709) [2] (225) [2]
Financial expenses (1,073) (1,293) [2],[6],[7] (430) [2],[6],[7],[8]
Financial income 519 584 [2],[6],[7] 205 [2],[6],[7],[8]
Liability recognised for estimated future royalties (291) (541)  
Interest rate and currency derivatives used to hedge debt      
Disclosure of detailed information about finance income expense [Line Items]      
Gain on derivatives used to manage debt (45) (67) (11)
Gain on derivatives used to manage cash and cash equivalents € (25) € (13) € 68
[1] (b)Includes net gains/(losses) on interest rate and currency derivatives used to manage debt: €(45) million in 2024, €(67) million in 2023, €(11) million in
2022.
[2] (a)Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued
operation.
[3] (c)Includes net gains on interest rate and currency derivatives used to manage cash and cash equivalents: €(25) million in 2024, €(13) million in 2023,
€68 million in 2022.
[4] (d)Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note D.19.).
[5] (e)Includes a financial expense of €291 million for the remeasurement of the liability recognized in the balance sheet for estimated future royalties on
Beyfortus sales in the US. In 2023, that expense amounted to €541 million, reflecting the successful launch of Beyfortus (see Note C.2.).
[6] (a)Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued
operation.
[7] Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation
[8] 2022 business operating income has been recast from the amount previously reported to include the one-time income of €952 million from the Libtayo transaction (€706 million net of tax)